Overview

To expand reach among U.S. Rheumatologists, Amgen initiated a groundbreaking Digital Opinion Leader (DOL) pilot program—"The Chat Rheum"—featuring prominent rheumatology expert Dr. Alvin Wells. Operating within strict pharmaceutical regulatory guidelines, the initiative sought to leverage modern social platforms to drive peer-to-peer HCP (Healthcare Professional) engagement across Eastern, Central, and Pacific time zones. As Technical Architect and Digital Project Lead, I spearheaded the technical deployment, channel configuration, social campaign infrastructure, platform troubleshooting, and cross-system data integration to turn complex compliance frameworks into an active, high-performing digital event pipeline.

Strategic Intent: Multi-Channel Digital Engagement & Regulatory Guardrails

The program was engineered to establish a regulatory proof-of-concept for DOL social media activation while driving targeted HCP event registration and participation.

• Compliance & Operational Blueprints: I led technical and infrastructure workflows alongside legal and medical teams to establish Fair Market Value (FMV) processes, Medical/Regulatory/Compliance (MAC) concept reviews, and secure account access protocols for DOL activities.
• Cross-Platform Audience Activation: Designed multi-channel promotional pathways leveraging Amgen Rep-Triggered Emails, Dr. Wells' professional social profiles, and targeted LinkedIn Sponsored InMail campaigns.

Hybrid Event Architecture & Agile Technical Pivots

To navigate unexpected platform rules and broadcast eligibility constraints, I architected a hybrid distribution model to ensure reliable delivery.

• Platform Feature Adaptation: When native LinkedIn Live broadcast eligibility requirements shifted during pre-event staging, I executed an immediate technical pivot to a multi-tiered Zoom Webinar broadcast model integrated directly within the LinkedIn Events framework.
• Staging & Platform Bug Resolution: Configured LinkedIn Events directly on Dr. Wells' professional profile and diagnosed a native LinkedIn platform bug where test events could not be removed post-staging, establishing operational workarounds to maintain clean public-facing channels.
• Cross-System Tracking Integration: Standardized data tracking across disparate touchpoints—including LinkedIn Events, Amgen sales force rep-triggered emails, Cvent, and Zoom webinar logs—to monitor top-of-funnel conversion.

Campaign Infrastructure & Target Social Drivers

The digital promotional engine was optimized to capture targeted HCP interest across time zones while expanding reach beyond native networks.

• Targeted InMail Deployment: Configured and deployed LinkedIn Sponsored InMail campaigns targeting verified HCP parameters, driving exceptional top-of-funnel traffic.
• Content & Event Staging: Co-authored and published structured social post cadences and event landing pages for Dr. Wells, incorporating trackable Bit.ly links to measure real-time click-through performance.
• Multi-Region Virtual Delivery: Successfully deployed and hosted three time-zone-specific virtual events across Eastern, Central, and Pacific regions.

Measurable Impact & Benchmark Performance

The pilot yielded industry-leading engagement metrics, providing key data and actionable insights for future pharma social strategies.

• High-Converting InMail Strategy: Achieved a 37.1% Click-Through Rate (CTR) on Sponsored InMail—vastly outperforming industry benchmarks for Healthcare/Fitness (2.57%) and Medical/Dental verticals (2.42%)—alongside a 32% response rate against a 2.5% industry baseline.
• Flawless Execution Across Time Zones: Delivered 3 live sessions serving 95 actual attendees across three regional time zones via integrated Zoom and LinkedIn channels.
• Scalable Process Framework: Documented key learnings regarding registration friction, pre-event engagement windows, and cross-platform CRM data reconciliation to guide future brand programs.

Key Insight: Successfully executing innovation in regulated environments requires balancing technical adaptability with compliance rigors[cite: 1, 2]. By pivoting platform architectures seamlessly and establishing robust cross-channel tracking, I delivered a benchmark-setting proof-of-concept that transformed traditional HCP engagement into an active, high-performing digital pipeline.